Gastrointestinal Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global gastrointestinal therapeutics market size reached US$ 44.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 59.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2022-2028.
Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.
The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, route of administration, application and distribution channel.
Breakup by Type:
Branded
Generic
Breakup by Route of Administration:
Oral
Intravenous
Others
Breakup by Application:
Ulcerative Colitis
Crohn's Disease
GERD
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.
Key Questions Answered in This Report:
How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global gastrointestinal therapeutics market and who are the key players?
What is the degree of competition in the industry?
Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.
The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, route of administration, application and distribution channel.
Breakup by Type:
Branded
Generic
Breakup by Route of Administration:
Oral
Intravenous
Others
Breakup by Application:
Ulcerative Colitis
Crohn's Disease
GERD
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.
Key Questions Answered in This Report:
How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global gastrointestinal therapeutics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Branded
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generic
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Ulcerative Colitis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Crohn's Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 GERD
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AbbVie Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca Plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Bausch Health Companies Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Bayer Aktiengesellschaft
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 GlaxoSmithKline Plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Novo Nordisk A/S
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Takeda Pharmaceuticals
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Branded
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generic
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Ulcerative Colitis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Crohn's Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 GERD
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AbbVie Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca Plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Bausch Health Companies Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Bayer Aktiengesellschaft
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 GlaxoSmithKline Plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Novo Nordisk A/S
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Takeda Pharmaceuticals
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
Table 8: Global: Gastrointestinal Therapeutics Market: Key Players
Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
Table 8: Global: Gastrointestinal Therapeutics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2022
Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2022
Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2022
Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter’s Five Forces Analysis
Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2022
Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2022
Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2022
Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter’s Five Forces Analysis
